Abstract
BackgroundAnti-TNF alpha (TNFi) drug survival is one of the relevant outcome measure in rheumatological diseases.ObjectivesObjective of this study was to compare TNFi drug survival in ankylosing spondylitis (AS) and axial...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
